http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-9804565-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 1998-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0430ac0926ef73f964b7d31ce0b18260 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58805ae07275869223b359d75c51ac45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5e4ac2c8273fffd07dcf4a268b40583 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e09fe890ff7f13402cb371632da864c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_953f9f8f3f53cef125ac22db732491c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba2f181984daf20663bd5dd572a94c91 |
| publicationDate | 1998-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-9804565-A |
| titleOfInvention | DERIVATIVES OF 3-PIRAZOLCARBOXAMIDE WITH AN AFFINITY FOR THE CANABINOID RECEPTOR. |
| abstract | The present invention relates to the compounds of formula (I): wherein, -Z1 represents a group -NR1R2 or a group -OR2; - g2, g3, g4, g5, and W2, W3, W4, W5, W6, are identical or different, and each independently represents hydrogen, a halogen atom, a (C1-C4) -alkyl, a (C1- C4) -alkoxy, a trifluoromethyl, a nitro, a (C1-C4) -alkylthio; with the proviso that at least one of the substituents g2, g3, g4, g5, g6 and at least one of, the substituents W2, W3, W4, W5, W6 are different from hydrogen; - R1 represents hydrogen or a (C1-C4) -alkyl; - R2 represents a non-aromatic carbocyclic radical in (C3-C15) unsubstituted or substituted one or more times by a substituent chosen from: a halogen atom, a (C1-C4) -alkyl, a (C1-C4) -alkoxy ; - represents hydrogen or a -CH2-R6 group; - R4 and R5 each independently represent a hydrogen, a (C1-C4) -alkyl or a trifluoromethyl; - or R4 represents hydrogen and R5 and W6 together constitute an ethylene radical or a trimethylene radical; - R6 represents hydrogen, or when the substituents g2, g3, g4, g5 and / or g6 are different from a (C1-C4) -alkyl, R6 represents hydrogen, a (C1-C4) -alkyl, a fluorine, a hydroxy , a (C1-C5) -alkoxy, a (C1-C5) -alkylthio, a hydroxy (C1-C5) -alkoxy, a cyano, a (C1-C5) -alkylsulfinyl, a (C1-C5) -alkylsulfonyl; and their salts, a process for their preparation and the pharmaceutical compositions that contain them, these compounds have a good affinity for CB2 receptors. |
| priorityDate | 1995-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.